Zobrazeno 1 - 1
of 1
pro vyhledávání: '"621"'
Publikováno v:
Drug Metabolism and Disposition. 36:2414-2418
Imatinib, a potent and selective protein tyrosine kinase inhibitor, has been approved for the treatment of chronic myelogenous leukemia and metastatic and unresectable malignant gastrointestinal stromal tumors. In vitro metabolism of imatinib was inv